Intact Investment Management Inc. Edwards Lifesciences Corp Transaction History

Intact Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$84.3 - $94.31 $349,845 - $391,386	-4,150 Reduced 71.55%	1,650 $152,000
Q1 2024 May 03, 2024	SELL	$72.54 - $95.56 $304,668 - $401,352	-4,200 Reduced 42.0%	5,800 $554,000
Q4 2023 Feb 02, 2024	BUY	$61.71 - $77.76 $617,100 - $777,600	10,000 New	10,000 $762,000
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $580,550 - $743,240	8,500 New	8,500 $634,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Intact Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Intact Investment Management Inc. with notifications on news.